Overview

Dose-ranging Study of SPL7013 Gel for the Prevention of Bacterial Vaginosis (BV)

Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The purpose in this clinical study is to determine the efficacy of SPL7013 Gel for the prevention of recurrence of bacterial vaginosis.
Phase:
Phase 2
Details
Lead Sponsor:
Starpharma Pty Ltd